Ropivacaine 0,75% in PENG block — Competitive Intelligence Brief

Ropivacaine 0,75% in PENG block (Ropivacaine 0,75% in PENG block) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide). Area: Anesthesia/Pain Management.

marketed Local anesthetic (amide) Voltage-gated sodium channels Anesthesia/Pain Management Small molecule

Target snapshot

Ropivacaine 0,75% in PENG block (Ropivacaine 0,75% in PENG block) — University of Liege. Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce regional anesthesia.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Ropivacaine 0,75% in PENG block TARGET	Ropivacaine 0,75% in PENG block	University of Liege	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Xylocaine with Epinephrine	Xylocaine with Epinephrine	Vrije Universiteit Brussel	marketed	Local anesthetic with vasoconstrictor	Voltage-gated sodium channels; alpha-1 adrenergic receptors
Lidocaine Hydrochloride Preservative Free	Lidocaine Hydrochloride	Pfizer Inc.	marketed	Local anesthetic (amide class)	Voltage-gated sodium channels (Nav)
Tegretol®	Tegretol®	University of Malaya	marketed	Anticonvulsant; mood stabilizer	Voltage-gated sodium channels
Xylocaine and Dexamethasone	Xylocaine and Dexamethasone	University of Jordan	marketed	Local anesthetic + corticosteroid combination	Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone)
Plain bupivacaine	Plain bupivacaine	Fayoum University Hospital	marketed	Local anesthetic	Voltage-gated sodium channels
Lidocaine 1%/Epi 1:200000	Lidocaine 1%/Epi 1:200000	Wahba bakhet	marketed	Local anesthetic with vasoconstrictor	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide) class)

1. Poznan University of Medical Sciences · 4 drugs in this class
2. Nantes University Hospital · 3 drugs in this class
3. Bozyaka Training and Research Hospital · 2 drugs in this class
4. ASST Gaetano Pini-CTO · 2 drugs in this class
5. Centre Hospitalier Universitaire de Nīmes · 1 drug in this class
6. Chiang Mai University · 1 drug in this class
7. Beijing Tiantan Hospital · 1 drug in this class
8. Complejo Hospitalario Universitario de Granada · 1 drug in this class
9. Ciusss de L'Est de l'Île de Montréal · 1 drug in this class
10. China Medical University, China · 1 drug in this class